These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27580108)

  • 1. Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs.
    Watanabe M; Osada H; Shimizu S; Goto S; Nagai M; Shirai J; Sasaki K; Shimoda M; Itoh H; Ohmori K
    Am J Vet Res; 2016 Sep; 77(9):969-75. PubMed ID: 27580108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
    Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF
    J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
    Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
    J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium.
    Schwinger RH; Böhm M; La Rosée K; Erdmann E
    Am Heart J; 1992 Aug; 124(2):320-30. PubMed ID: 1322030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PAF on histamine H1 receptor mRNA expression in rat trigeminal ganglia.
    Nakasaki T; Masuyama K; Fukui H; Ogino S; Eura M; Samejima Y; Ishikawa T; Yumoto E
    Prostaglandins Other Lipid Mediat; 1999 Aug; 58(1):29-41. PubMed ID: 10482285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
    Kahhak L; Roche A; Dubray C; Arnoux C; Benveniste J
    Inflamm Res; 1996 May; 45(5):234-8. PubMed ID: 8737746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
    Foster AP; Cunningham FM; Andrews MJ; Lees P
    J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Y-24180, an antagonist at platelet-activating factor (PAF) receptors, on IgE-mediated cutaneous reactions in mice.
    Yamaguchi S; Tomomatsu N; Kagoshima M; Okumoto T; Komatsu H
    Inflamm Res; 1998 Dec; 47(12):506-11. PubMed ID: 9892046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry.
    Rocha FA; Jancar S; Fraga CA; Timo-Iaria C; De Brum-Fernandes AJ
    J Rheumatol; 1993 Aug; 20(8):1374-7. PubMed ID: 8230022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
    Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
    J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species.
    Carolan EJ; Casale TB
    J Immunol; 1990 Oct; 145(8):2561-5. PubMed ID: 2170519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition by the PAF receptor antagonist, WEB 2170, of allergic inflammation in single sensitized and boosted mice.
    Amorim CZ; Martins MA; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1992 Jan; 211(1):29-33. PubMed ID: 1618265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.